Mickey K.

CBO @ Pep2Tango Therapeutics

About

Accomplished and results-driven executive with a successful track record of managing large multi-national teams and P&L (>$50M), driving revenue growth and operational efficiency, and closing M&A, partnership and licensing deals, in dynamic corporate settings. Expert in corporate development, strategy, growing revenues, driving EBITDA improvements and consistently delivering impactful outcomes. Well-versed in building, growing and leading large cross-functional, high-performing teams, managing innovation, developing deal strategies and influencing a wide variety of constituents from regulators to Board members to customers. Strategic thinker; skilled in identifying and developing strategies for new products and markets. Wide breadth of deal-making success across multiple deal types (M&A, partnerships, licensing, services) from deal sourcing to portfolio strategy to leading negotiations to transaction execution to post-merger integration. Completed ~$800M worth of transactions.

Country

United States

City

Washington DC-Baltimore Area

Industry

Biotechnology

Skill

M&A, Cyber-security, Risk Management, Organizational Development, Resource Management, Patient Advocacy, P&L Analysis, Coaching & Mentoring, Presentations, Strategic Initiatives, Crisis Management, Contract Terms, Community Relations, Capital Expenditures, Strategic Planning, Program Management, Operations Management, Manufacturing Process Improvement, Management, Business Strategy

Experience

CBO

Pep2Tango Therapeutics

2025 - Present · 1 yr

CBO

Axiom Biosciences

2024 - 2025 · 1 yr

SVP, Head of Global Products and Corporate Development

CareDx, Inc.

2022 - 2023 · 1 yr

General manager for Global Products (kitted diagnostic tests & software; IVDD/IVDR in EU, RUO in US) business with commercial operations across the Americas, Europe, MENA, APAC and manufacturing in Australia, Sweden and the US. Grew revenues, increased EBITDA profitability and improved COGS.

SVP, Corporate Development & Strategy

CareDx, Inc.

2021 - 2023 · 2 yrs

Led all M&A, business development, partnerships and alliance management activities. Managed business development team.

Consultant

Bright Healthcare Innovations

2020 - 2020

Advisory and consulting for public and private healthcare and life science companies.

President, Inova Translational Medicine Institute

Inova Health

2018 - 2019 · 1 yr

Led this genomics research institute with a portfolio of personalized medicine products and externally partnered research projects. Institute also provided CAP/CLIA laboratory, biorepository and genetic counselor services and deployed a team of data scientists.

Senior Vice President, Research & Commercialization

Inova Health

2017 - 2019 · 2 yrs

Senior health system executive that developed research strategy and restructured research operations for the health system. Managed significant operational budget and led a diverse staff of research, administrative, data management and translational medicine colleagues.

Head, Out-licensing & Spin outs

MedImmune

2015 - 2017 · 2 yrs

Led cross-functional teams developing business concepts for and marketing internal small molecule and mAb assets for spin out and out-licensing. Completed deals represent over $650 mm of potential value.

Director, Global Partnerships

MedImmune

2013 - 2015 · 2 yrs

Led cross-functional teams developing strategy for and closing global partnership deals, including Cancer Research UK - MedImmune Alliance Laboratory.